Tower Research Capital LLC (TRC) - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 46 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$12,000
-29.4%
14,709
-41.5%
0.00%0.0%
Q2 2019$17,000
+240.0%
25,134
+287.0%
0.00%
Q1 2019$5,000
-70.6%
6,495
-40.3%
0.00%
-100.0%
Q4 2018$17,000
-67.9%
10,884
-32.1%
0.00%
-75.0%
Q3 2018$53,000
+96.3%
16,031
+33.6%
0.00%
+100.0%
Q2 2018$27,000
+2600.0%
12,001
+5669.7%
0.00%
Q1 2018$1,000
-99.0%
208
-99.4%
0.00%
-100.0%
Q4 2017$96,00034,3780.01%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
Q4 2016$1,000
-97.5%
1,076
-97.6%
0.00%
-100.0%
Q3 2016$40,000
+21.2%
45,344
+34.0%
0.00%
+33.3%
Q2 2016$33,000
+3200.0%
33,843
+1967.4%
0.00%
Q1 2016$1,000
-66.7%
1,637
-37.8%
0.00%
Q4 2015$3,000
-70.0%
2,630
-67.9%
0.00%
-100.0%
Q3 2015$10,000
+400.0%
8,190
+478.8%
0.00%
Q2 2015$2,0001,415
+1315.0%
0.00%
Q3 2014$0
-100.0%
100
-99.5%
0.00%
-100.0%
Q1 2014$29,000
+190.0%
19,496
+387.9%
0.00%
+300.0%
Q2 2013$10,0003,9960.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 20,896,038$17,135,0000.89%
X-Square Capital, LLC 270,680$222,0000.15%
New Leaf Venture Partners, L.L.C. 402,118$330,0000.09%
GSA CAPITAL PARTNERS LLP 688,431$565,0000.06%
WealthTrust Axiom LLC 138,505$113,0000.04%
EXCALIBUR MANAGEMENT CORP 51,000$42,0000.04%
Caption Management, LLC 855,200$701,0000.04%
Evercore Wealth Management, LLC 418,414$343,0000.01%
Gemmer Asset Management LLC 1,939$32,0000.01%
Ausdal Financial Partners, Inc. 23,000$19,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders